0001525594-14-000001.txt : 20140325 0001525594-14-000001.hdr.sgml : 20140325 20140325160818 ACCESSION NUMBER: 0001525594-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140325 DATE AS OF CHANGE: 20140325 EFFECTIVENESS DATE: 20140325 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Variation Biotechnologies (US), Inc. CENTRAL INDEX KEY: 0001525594 IRS NUMBER: 980526196 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-214214 FILM NUMBER: 14716075 BUSINESS ADDRESS: STREET 1: 222 3RD STREET STREET 2: SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: (617) 830-3031 MAIL ADDRESS: STREET 1: 222 3RD STREET STREET 2: SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02141 D 1 primary_doc.xml X0707 D LIVE 0001525594 Variation Biotechnologies (US), Inc. 222 3RD STREET SUITE 2241 CAMBRIDGE MA MASSACHUSETTS 02142 (617) 830-3031 DELAWARE None None Corporation true Jeff Baxter 222 3rd Street Suite 2241 Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Chief Executive Officer, President and Director Egidio Nascimento 222 3rd Street Suite 2241 Cambridge MA MASSACHUSETTS 02142 Executive Officer Chief Financial Officer Michael Steinmetz 222 3rd Street Suite 2241 Cambridge MA MASSACHUSETTS 02142 Director Stephen Gillis 222 3rd Street Suite 2241 Cambridge MA MASSACHUSETTS 02142 Director Kevin Forrest 222 3rd Street Suite 2241 Cambridge MA MASSACHUSETTS 02142 Director Steve Vignau 222 3rd Street Suite 2241 Cambridge MA MASSACHUSETTS 02142 Director David E. Anderson 222 3rd Street Suite 2241 Cambridge MA MASSACHUSETTS 02142 Executive Officer Vice President, Research Biotechnology Decline to Disclose 06b false 2014-03-10 false true true false 0 Middlebury Securities, LLC 122602 Middlebury Securities, LLC 122602 1043 Sheep Farm Road Weybridge VT VERMONT 05753 AZ ARIZONA AR ARKANSAS CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE DC DISTRICT OF COLUMBIA FL FLORIDA IL ILLINOIS ME MAINE MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA NV NEVADA NH NEW HAMPSHIRE NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA PA PENNSYLVANIA SC SOUTH CAROLINA TX TEXAS UT UTAH VT VERMONT VA VIRGINIA WI WISCONSIN WY WYOMING false Palladium Capital Advisors, LLC 129400 Palladium Capital Advisors, LLC 129400 230 Park Avenue Suite 539 New York NY NEW YORK 10169 CA CALIFORNIA CT CONNECTICUT FL FLORIDA IL ILLINOIS NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA TX TEXAS false 1500000 1500000 0 false 8 65000 0 Middlebury and Palladium received 6% and 7%, for their $500K placements, respectively. 250000 true Approx. $250K in ordinary course compensation and board fees to be paid to named officers and directors. false Variation Biotechnologies (US), Inc. /s/ Egidio Nascimento Egidio Nascimento CFO 2014-03-25